---
figid: PMC5992473__gr9
figtitle: Schematic Illustrates a Model of miR372 Promotes Liver Cancer Cell Growth
  by Upregulating erbB-2 through Enhancing YB-1 via Targeting for PTENmiR372 accelerates
  malignant progression of liver cancer cells in vitro and in vivo
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
- Sesamum indicum
pmcid: PMC5992473
filename: gr9.jpg
figlink: /pmc/articles/PMC5992473/figure/fig9/
number: F9
caption: The Schematic Illustrates a Model of miR372 Promotes Liver Cancer Cell Growth
  by Upregulating erbB-2 through Enhancing YB-1 via Targeting for PTENmiR372 accelerates
  malignant progression of liver cancer cells in vitro and in vivo. Mechanistically,
  miR372 enhances expression of YB-1 and consequently promotes phosphorylation of
  YB-1 via HULC looping dependent on ERK1/2 and PTEN. Moreover, miR372 inhibits the
  degradation of β-catenin dependent on phosphorylation of YB-1 and then enhances
  the expression and activity PKM2 by β-catenin-LEF/TCF4 pathway. Furthermore, the
  loading of LEF/TCF4 on PKM2 promoter region is significantly increased in miR372-overexpressed
  liver cancer cells. Ultimately, miR372 promotes the expression of erbB-2 through
  PKM2-pH3T11-H3K9Ac pathway.
papertitle: miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2
  through Enhancement of YB-1.
reftext: Zhuojia Lin, et al. Mol Ther Nucleic Acids. 2018 Jun 1;11:494-507.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9223843
figid_alias: PMC5992473__F9
figtype: Figure
organisms_ner:
- Homo sapiens
- Bos taurus
- Mus musculus
- Oryctolagus cuniculus
redirect_from: /figures/PMC5992473__F9
ndex: 5cffd368-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5992473__gr9.html
  '@type': Dataset
  description: The Schematic Illustrates a Model of miR372 Promotes Liver Cancer Cell
    Growth by Upregulating erbB-2 through Enhancing YB-1 via Targeting for PTENmiR372
    accelerates malignant progression of liver cancer cells in vitro and in vivo.
    Mechanistically, miR372 enhances expression of YB-1 and consequently promotes
    phosphorylation of YB-1 via HULC looping dependent on ERK1/2 and PTEN. Moreover,
    miR372 inhibits the degradation of β-catenin dependent on phosphorylation of YB-1
    and then enhances the expression and activity PKM2 by β-catenin-LEF/TCF4 pathway.
    Furthermore, the loading of LEF/TCF4 on PKM2 promoter region is significantly
    increased in miR372-overexpressed liver cancer cells. Ultimately, miR372 promotes
    the expression of erbB-2 through PKM2-pH3T11-H3K9Ac pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIR372
  - PTEN
  - CTCF
  - HULC
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - YBX1
  - MAPK3
  - MAPK1
  - ERBB2
  - PKM
  - PKLR
  - CTNNB1
  - CCNE1
  - CCNE2
  - CDK2
  - TCF4
  - TCF7L2
  - EP300
  - POLR1A
  - POLR1B
  - POLR1C
  - POLR1D
  - Pten
  - Ctcf
  - Creb1
  - Ybx1
  - Mapk3
  - Mapk1
  - Erbb2
  - Pkm
  - Ctnnb1
  - Cdk2
  - Tcf4
  - Tcf7l2
  - Ep300
  - TCF4
  - glycosis
---
